Gerald T Proehl insider trades: Dermata Therapeutics (DRMA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Gerald reports to the SEC
and 1 more company
Open-market buys and sales
28 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 23, 2021 | DRMA | ↑ Buy | 20,000 | $2.40 | $48K | Direct | Nov 26, 2021 (3d) |
| Aug 16, 2021 | DRMA | ↑ Buy | 10,000 | $4.96 | $50K | By Proehl Family Trust | Aug 17, 2021 (1d) |
| Nov 23, 2016 | TENX | ↑ Buy | 29,882 | $1.67 | $50K | Direct | Nov 29, 2016 (6d) |
| Jun 24, 2015 | RTTR | ↑ Buy | 50,000 | $5.00 | $250K | Direct | Jun 25, 2015 (1d) |
| Sep 19, 2014 | ASPX | ↑ Buy | 1,466 | $21.75 | $32K | Direct | Sep 22, 2014 (3d) |
| Sep 19, 2014 | SPHS | ↑ Buy | 10,000 | $3.16 | $32K | Direct | Sep 19, 2014 (0d) |
| Dec 16, 2013 | SNTS | ↓ Sell | 56,643 | $31.95 | $1.8M | By Family Trust | Dec 17, 2013 (1d) |
| Nov 15, 2013 | SNTS | ↓ Sell | 56,644 | $32.02 | $1.8M | By Family Trust | Nov 19, 2013 (4d) |
| Oct 15, 2013 | SNTS | ↓ Sell | 50,000 | $22.32 | $1.1M | By Family Trust | Oct 16, 2013 (1d) |
| Sep 16, 2013 | SNTS | ↓ Sell | 50,000 | $22.19 | $1.1M | By Family Trust | Sep 17, 2013 (1d) |
| May 6, 2013 | SNTS | ↓ Sell | 86,603 | $18.73 | $1.6M | Direct | May 7, 2013 (1d) |
| Apr 4, 2013 | SNTS | ↓ Sell | 86,601 | $16.75 | $1.5M | Direct | Apr 5, 2013 (1d) |
| Mar 4, 2013 | SNTS | ↓ Sell | 86,601 | $13.57 | $1.2M | Direct | Mar 5, 2013 (1d) |
| Feb 4, 2013 | SNTS | ↓ Sell | 86,601 | $12.98 | $1.1M | Direct | Feb 5, 2013 (1d) |
| Mar 16, 2009 | SNTS | ↑ Buy | 40,000 | $1.22 | $49K | Direct | Mar 16, 2009 (0d) |
| Dec 11, 2007 | SNTS | ↑ Buy | 25,000 | $2.72 | $68K | Direct | Dec 12, 2007 (1d) |
| Feb 28, 2007 | SNTS | ↓ Sell10b5-1 | 10,000 | $6.58 | $66K | Direct | Mar 1, 2007 (1d) |
| Jan 24, 2007 | SNTS | ↓ Sell10b5-1 | 10,000 | $6.96 | $70K | Direct | Jan 25, 2007 (1d) |
| Oct 16, 2006 | SNTS | ↓ Sell10b5-1 | 12,500 | $8.34 | $104K | Direct | Oct 17, 2006 (1d) |
| Sep 15, 2006 | SNTS | ↓ Sell10b5-1 | 12,500 | $8.25 | $103K | Direct | Sep 19, 2006 (4d) |
| Aug 15, 2006 | SNTS | ↓ Sell10b5-1 | 12,500 | $6.24 | $78K | Direct | Aug 16, 2006 (1d) |
| Jul 20, 2006 | SNTS | ↓ Sell10b5-1 | 7,448 | $6.00 | $45K | Direct | Jul 21, 2006 (1d) |
| Jul 17, 2006 | SNTS | ↓ Sell10b5-1 | 5,052 | $6.00 | $30K | Direct | Jul 18, 2006 (1d) |
| Jun 15, 2006 | SNTS | ↓ Sell | 12,500 | $6.01 | $75K | Direct | Jun 16, 2006 (1d) |
| May 15, 2006 | SNTS | ↓ Sell | 12,500 | $6.98 | $87K | Direct | May 16, 2006 (1d) |
| Apr 17, 2006 | SNTS | ↓ Sell | 12,500 | $7.92 | $99K | Direct | Apr 19, 2006 (2d) |
| Mar 15, 2006 | SNTS | ↓ Sell | 12,500 | $6.27 | $78K | Direct | Mar 17, 2006 (2d) |
| May 31, 2005 | SNTS | ↑ Buy | 10,000 | $3.11 | $31K | Direct | May 31, 2005 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other DRMA insiders
Open-market trades in the last 12 months
About Gerald T Proehl's insider trades
Gerald T Proehl is President, CEO and Chairman at Dermata Therapeutics (DRMA). Since May 31, 2005, Gerald has reported 9 open-market purchases worth $609K and 19 sales worth $12.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
7 sales (4% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (36 filings), option exercises (12 filings), other transactions (4 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DRMA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.